Windtree Therapeutics Inc /De/

Ownership Transactions Reported by 16 Insiders

Symbol
WINT on Nasdaq, WINTW on OTC
Location
2600 Kelly Road, Suite 100, Warrington, PA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Windtree Therapeutics Inc /De/ executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James Huang Director $3.82M Feb 22, 2023
Center Laboratories, Inc. 10%+ Owner $2.53M May 20, 2020
John Hamill Svp & Cfo $74.2K Jul 26, 2022
Craig Fraser President and CEO, Director $59K Oct 8, 2024
Steven Simonson SVP, Chief Medical Officer $17.8K Jul 22, 2024
Eric Curtis Svp & Coo $16.2K Aug 23, 2023
Jamie McAndrew VP, Controller, & CAO $10.4K Aug 24, 2023
Mark Strobeck Director $2.35K Aug 23, 2023
Daniel E. Geffken Director $2.22K Aug 23, 2023
Leslie J. Williams Director $2.18K Aug 23, 2023
Robert A. Scott Director $2.18K Aug 23, 2023
Diane Carman SVP & General Counsel $1.25K Feb 28, 2023
John A. Tattory Interim CFO Jan 27, 2023
Saundra L. Pelletier Director Aug 13, 2024
Jed Latkin Director Aug 13, 2024
Bioengine Capital Inc. 10%+ Owner May 20, 2020

Recent Insider Transactions by Companies or Individuals for Windtree Therapeutics Inc /De/

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.